Functional and oncologic results of the surgical salvage in the management of recurrent nasopharyngeal carcinomas;Resultados oncológicos y funcionales de la cirugía de rescate en las recidivas locales de los carcinomas nasofaríngeos

Acta Otorrinolaringologica Espanola

Volumn 56, Issue 9, 2005, Pages 416-422

  Cabanillas Farpón, Rubén ^a,b   Llorente, J L ^a   Estelrrich, P M ^a   Martinez Cassati M E ^a   Franco, V ^a   Suarez C ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b NONE   (Spain)

Author keywords

Carcinoma; Facial translocation; Nasopharyngeal; Salvage; Subtemporal preauricular; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DISEASE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; NASOPHARYNX CARCINOMA; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL TIME; MIDDLE AGED; NASOPHARYNX TUMOR; SALVAGE THERAPY; TUMOR RECURRENCE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; SALVAGE THERAPY;

EID: 33644946287     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-6519(05)78640-4     Document Type: Article

References (28)

1. Lee AW, Law SC, Foo W, Poon YF, Chan DK, O SK, et al. Nasopharyngeal carcinoma: local control by megavoltage irradiation. Br J Radiol 1993;66:528-36.
2. Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, Morrison WH, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997;37:985-96.
3. Sutton JB, Green JP, Meyer JL, Louie D, Heltzel M, Karp AH. Nasopharyngeal carcinoma. A study examining Asian patients treated in the United States. Am J Clin Oncol 1995;18:337-42.
4. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310-1317.
5. Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005;97:536-9.
6. Chan AT, Teo PM, Jonson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002;13(7):1007-1015.
7. Chen KY, Fletcher GH. Malignant tumours of the nasopharynx. Radiol 1971;99:165-171.
8. Choy D, Sham JST, Wei WI, Ho CM, Wu PM. Transpalatal insertion of radioactive gold grain for the treatment of peristent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:505-512.
9. To EW, Teo PM, Ku PK, Pang PC. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: an innovative transnasal approach through a mid-face deglove incision with stereotactic navigation guidance. Br J Oral Maxillofac Surg 2001;39:55-62.
10. Wei WI. Cancer of the nasopharynx: functional surgical salvage. World J Surg 2003;27:844-8.
11. Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO. How successful is high-dose (≥60 Gy) re irradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?. Int J Radiat Oncol Biol Phys 1998;40:897-913.
12. Choy D, Sham JS, Wei WI, Ho CM, Wu PM. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:505-512.
13. King WW, Ku PK, Mok CO, Teo PM. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck 2000;22:215-222.
14. Wei WI, Lam KH, Sham JS. New approach to the nasopharynx: the maxillary swing approach. Head Neck 1991;13:200-207.
15. Fee WE Jr, Moir MS, Choi EC, Goffinet D. Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg 2002;128:280-284.
16. Fee WE Jr, Roberson JB Jr, Goffinet DR. Long-term survival after surgical resection for recurrent nasopharyngeal cancer after radiotherapy failure. Arch Otolaryngol Head Neck Surg 1991;117:1233-1236.
17. Janecka IP, Sen CN, Sekhar LN, Arriaga M. Facial translocation: a new approach to the cranial base. Otolaryngol Head Neck Surg 1990;103:413-9.
18. Suarez C, Llorente JL, Munoz C, Garcia LA, Rodrigo JP. Facial translocation approach in the management of central skull base and infratemporal tumors. Laryngoscope 2004;114:1047-51.
19. Llorente JL, Nazar G, Cabanillas R, Fernández de León R, Suárez C. Subtemporal-preauricular approach to the infratemporal fossa. J Otolaryngol (en prensa).
20. Pryzant RM, Wendt CD, Delclos L, Peters LJ. Re-treatment of nasopharyngeal carcinomain 53 patients. Int J Radiat Oncol Biol Phys 1992;22:941-947.
21. Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-44.
22. Hareyama M, Sakata K, Shirato H, Nishioka T, Nishio M, Suzuki K, et al. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 2002;94:2217-23.
23. To EW, Lai EC, Cheng JH, Pang PC, Williams MD, Teo PM. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors. Laryngoscope 2002;112:1877-82.
24. Chang KP, Hao SP, Tsang NM, Ueng SH. Salvage surgery for locally recurrent nasopharyngeal carcinoma-A 10-year xperience. Otolaryngol Head Neck Surg 2004;131(4):497-502.
25. Shu CH, Cheng H, Lirng JF, Chang FC, Chao Y, Chi KH, et al. Salvage surgery for recurrent nasopharyngeal carcinoma. Laryngoscope 2000;110:1483-8.
26. Hao SP. Facial translocation approach to the skull base: the viability of translocated facial bone graft. Otolaryngol Head Neck Surg 2001;124:292-296.
27. Hao SP, Tsang NM, Chang KP. Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and epstein-barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma. Laryngoscope 2004;114:2027-30.
28. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, et al. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 2004;100:1162-70.